Aurobindo Irbesartan Class Action Settlement 2026

See details

Max Payout

TBD

Filing Deadline

See Details

Proof Required?

Aurobindo Pharma has agreed to pay $2 million to settle a class action lawsuit over allegedly contaminated blood pressure medication. The lawsuit claims that Aurobindo's irbesartan tablets contained NDEA, a chemical classified as a probable human carcinogen by health authorities. If you purchased Aurobindo irbesartan tablets between January 2016 and now, you may be entitled to compensation from this settlement. The contamination affects a widely-used generic blood pressure medication that millions of Americans rely on for their cardiovascular health.

Who Is Eligible?

You may be eligible to file a claim if you:

You purchased Aurobindo brand irbesartan tablets (a blood pressure medication)
Your purchase occurred between January 1, 2016 and the present day
You bought the medication in the United States
You have documentation of your purchase (pharmacy records, receipts, or insurance claims)

How Much Can You Get?

The total settlement fund is $2 million, which will be distributed among qualifying class members. Individual payout amounts have not been announced yet and will depend on factors like how many people file valid claims and how much contaminated medication each person purchased. Payment amounts will be determined after the claim filing deadline passes and all valid claims are reviewed. Details about specific compensation amounts should become available as the settlement administration process continues.

How to File Your Claim

Filing your claim is quick and easy:

Gather documentation showing you purchased Aurobindo irbesartan tablets between January 2016 and now
This may include pharmacy receipts, insurance records, or prescription history
Wait for the official claim form to become available (the claim deadline is June 2, 2026)
Complete the claim form with your purchase information and submit required documentation
Download the Class Action Buddy app to get notified when the claim form is ready and get help filing your claim

💡 Easier way: File with Class Action Buddy

Skip the paperwork. Our app auto-fills your claim form with your saved profile and submits it electronically in under 2 minutes.

Download for iPhone Download for Android

Frequently Asked Questions

What is Aurobindo irbesartan and why was it contaminated

Aurobindo irbesartan is a generic blood pressure medication. The lawsuit alleges these tablets contained NDEA, a chemical that's considered a probable human carcinogen, meaning it may increase cancer risk.

How do I know if I took Aurobindo brand irbesartan

Check your prescription bottles, pharmacy records, or insurance claims for the manufacturer name 'Aurobindo.' Your pharmacist can also help you identify which brand you received.

When is the deadline to file an Aurobindo irbesartan claim

The claim filing deadline is June 2, 2026. The final approval hearing is scheduled for June 30, 2026, so make sure to file well before the June deadline.

Ready to File Your Claim?

We're adding new settlements regularly. Download the app to get notified when this one is available.

Download Class Action Buddy →

Or file directly at the settlement website →